Ajuba inhibits hepatocellular carcinoma cell growth via targeting of β-catenin and YAP signaling and is regulated by E3 ligase Hakai through neddylation

[1]  Xia Li,et al.  Basolateral CD147 induces hepatocyte polarity loss by E‐cadherin ubiquitination and degradation in hepatocellular carcinoma progress , 2018, Hepatology.

[2]  Yang Shi,et al.  Zc3h13 Regulates Nuclear RNA m6A Methylation and Mouse Embryonic Stem Cell Self-Renewal. , 2018, Molecular cell.

[3]  Jeong-Hwan Kim,et al.  Hippo-mediated suppression of IRS2/AKT signaling prevents hepatic steatosis and liver cancer , 2018, The Journal of clinical investigation.

[4]  H. Lee,et al.  Tumor‐adjacent tissue co‐expression profile analysis reveals pro‐oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma , 2017, Molecular oncology.

[5]  Yuxi Li,et al.  Hippo signaling pathway in liver tissue homeostasis. , 2017, Yi chuan = Hereditas.

[6]  P. Schirmacher,et al.  Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer. , 2017, Gastroenterology.

[7]  Huanbai Xu,et al.  The LIM protein AJUBA promotes colorectal cancer cell survival through suppression of JAK1/STAT1/IFIT2 network , 2017, Oncogene.

[8]  Xianming Deng,et al.  Hippo Signaling Suppresses Cell Ploidy and Tumorigenesis through Skp2. , 2017, Cancer cell.

[9]  Yue Wang,et al.  The oncoprotein HBXIP up-regulates YAP through activation of transcription factor c-Myb to promote growth of liver cancer. , 2017, Cancer Letters.

[10]  E. Jho,et al.  Hippo signaling interactions with Wnt/&bgr;-catenin and Notch signaling repress liver tumorigenesis , 2017, The Journal of clinical investigation.

[11]  G. Longmore,et al.  AJUBA LIM Proteins Limit Hippo Activity in Proliferating Cells by Sequestering the Hippo Core Kinase Complex in the Cytosol , 2016, Molecular and Cellular Biology.

[12]  Xueda Hu,et al.  AJUBA promotes the migration and invasion of esophageal squamous cell carcinoma cells through upregulation of MMP10 and MMP13 expression , 2016, Oncotarget.

[13]  Han Liu,et al.  Tumor suppressor Spred2 interaction with LC3 promotes autophagosome maturation and induces autophagy-dependent cell death , 2016, Oncotarget.

[14]  G. Mills,et al.  Yes‐associated protein 1 and transcriptional coactivator with PDZ‐binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma , 2016, Hepatology.

[15]  Songshu Meng,et al.  Oncolytic newcastle disease virus triggers cell death of lung cancer spheroids and is enhanced by pharmacological inhibition of autophagy. , 2015, American journal of cancer research.

[16]  E. Oki,et al.  An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell-like Behaviors Contributing to Disease Progression. , 2015, Cancer research.

[17]  W. Liu,et al.  Ajuba Preferentially Binds LXRα/RXRγ Heterodimer to Enhance LXR Target Gene Expression in Liver Cells. , 2015, Molecular endocrinology.

[18]  G. Longmore,et al.  Ajuba proteins , 2015, Current Biology.

[19]  Huanming Yang,et al.  Genomic Analyses Reveal Mutational Signatures and Frequently Altered Genes in Esophageal Squamous Cell Carcinoma , 2015, American journal of human genetics.

[20]  J. Llovet,et al.  YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor Regression. , 2015, Cell reports.

[21]  Xianming Deng,et al.  Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesis , 2015, Nature Communications.

[22]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.

[23]  Lanfen Chen,et al.  The Hippo signaling pathway in liver regeneration and tumorigenesis. , 2015, Acta biochimica et biophysica Sinica.

[24]  Curtis R. Pickering,et al.  Mutational Landscape of Aggressive Cutaneous Squamous Cell Carcinoma , 2014, Clinical Cancer Research.

[25]  J. Madri,et al.  Adhesion Molecule-Mediated Hippo Pathway Modulates Hemangioendothelioma Cell Behavior , 2014, Molecular and Cellular Biology.

[26]  Jian Sun,et al.  Genetic landscape of esophageal squamous cell carcinoma , 2014, Nature Genetics.

[27]  Lei Zhang,et al.  LIM protein JUB promotes epithelial–mesenchymal transition in colorectal cancer , 2014, Cancer science.

[28]  Y. Kondo,et al.  LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade , 2013, Oncogene.

[29]  D. Moore,et al.  Bile acids activate YAP to promote liver carcinogenesis. , 2013, Cell reports.

[30]  Makoto Naito,et al.  Identification of Wilms' Tumor 1-associating Protein Complex and Its Role in Alternative Splicing and the Cell Cycle* , 2013, The Journal of Biological Chemistry.

[31]  Takanori Fujita,et al.  PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer , 2013, Scientific Reports.

[32]  Jun Du,et al.  c-Cbl-mediated neddylation antagonizes ubiquitination and degradation of the TGF-β type II receptor. , 2013, Molecular cell.

[33]  Angélica Figueroa,et al.  miR-203 Regulates Cell Proliferation through Its Influence on Hakai Expression , 2012, PloS one.

[34]  J. Seetharaman,et al.  Structure of a novel phosphotyrosine‐binding domain in Hakai that targets E‐cadherin , 2012, The EMBO journal.

[35]  Angélica Figueroa,et al.  Biological influence of Hakai in cancer: a 10-year review , 2012, Cancer and Metastasis Reviews.

[36]  C. Cartwright,et al.  Rack1 promotes epithelial cell–cell adhesion by regulating E-cadherin endocytosis , 2012, Oncogene.

[37]  M. Bailly,et al.  Ajuba is required for Rac activation and maintenance of E-cadherin adhesion , 2011, The Journal of cell biology.

[38]  Angélica Figueroa,et al.  Hakai reduces cell-substratum adhesion and increases epithelial cell invasion , 2011, BMC Cancer.

[39]  J. Geng,et al.  Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis , 2011, Cell Research.

[40]  Keesook Lee,et al.  Hakai acts as a coregulator of estrogen receptor alpha in breast cancer cells , 2010, Cancer science.

[41]  G. Longmore,et al.  Ajuba LIM Proteins Are Negative Regulators of the Hippo Signaling Pathway , 2010, Current Biology.

[42]  J. Llovet,et al.  Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. , 2010, Seminars in liver disease.

[43]  Ping Li,et al.  Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ. , 2010, Molecular cell.

[44]  M. Gorospe,et al.  Hacking RNA: Hakai promotes tumorigenesis by enhancing the RNA-binding function of PSF , 2009, Cell cycle.

[45]  M. Gorospe,et al.  Novel roles of hakai in cell proliferation and oncogenesis. , 2009, Molecular biology of the cell.

[46]  Amanda Doucette,et al.  An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer , 2009, Nature.

[47]  Ellen M. Langer,et al.  Ajuba LIM proteins are snail/slug corepressors required for neural crest development in Xenopus. , 2008, Developmental cell.

[48]  T. Akiyama,et al.  Ajuba negatively regulates the Wnt signaling pathway by promoting GSK-3β-mediated phosphorylation of β-catenin , 2008, Oncogene.

[49]  T. Akiyama,et al.  Ajuba negatively regulates the Wnt signaling pathway by promoting GSK-3beta-mediated phosphorylation of beta-catenin. , 2008, Oncogene.

[50]  Derek Y. Chiang,et al.  Genomics and signaling pathways in hepatocellular carcinoma. , 2007, Seminars in liver disease.

[51]  S. Boyault,et al.  Differential effects of inactivated Axin1 and activated β-catenin mutations in human hepatocellular carcinomas , 2007, Oncogene.

[52]  S. Boyault,et al.  Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets , 2007, Hepatology.

[53]  G. Cesareni,et al.  Conjugation to Nedd8 Instigates Ubiquitylation and Down-regulation of Activated Receptor Tyrosine Kinases* , 2006, Journal of Biological Chemistry.

[54]  Songshu Meng,et al.  Participation of both Gab1 and Gab2 in the activation of the ERK/MAPK pathway by epidermal growth factor. , 2005, The Biochemical journal.

[55]  M. Beckerle,et al.  The LIM domain: from the cytoskeleton to the nucleus , 2004, Nature Reviews Molecular Cell Biology.

[56]  K. Green.  Faculty Opinions recommendation of Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. , 2002 .

[57]  W. Birchmeier,et al.  Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex , 2002, Nature Cell Biology.

[58]  Yusuke Nakamura,et al.  AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 , 2000, Nature Genetics.